Skip to main content

Peer Review reports

From: Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874]

Original Submission
3 Oct 2005 Submitted Original manuscript
24 Oct 2005 Author responded Author comments - Vanna Chiarion Sileni
Resubmission - Version 2
24 Oct 2005 Submitted Manuscript version 2
23 Dec 2005 Author responded Author comments - Vanna Chiarion Sileni
3 Nov 2005 Reviewed Reviewer Report - Mark Middleton
23 Nov 2005 Reviewed Reviewer Report - Claus Garbe
28 Nov 2005 Reviewed Reviewer Report - Sanjiv Agarwala
9 Dec 2005 Reviewed Reviewer Report - John Kirkwood
Resubmission - Version 3
23 Dec 2005 Submitted Manuscript version 3
27 Jan 2006 Author responded Author comments - Vanna Chiarion Sileni
4 Jan 2006 Reviewed Reviewer Report - Claus Garbe
23 Jan 2006 Reviewed Reviewer Report - Sanjiv Agarwala
3 Jan 2006 Reviewed Reviewer Report - John Kirkwood
Resubmission - Version 4
27 Jan 2006 Submitted Manuscript version 4
8 Feb 2006 Author responded Author comments - Vanna Chiarion Sileni
Resubmission - Version 5
8 Feb 2006 Submitted Manuscript version 5
Publishing
27 Feb 2006 Editorially accepted
27 Feb 2006 Article published 10.1186/1471-2407-6-44

You can find further information about peer review here.

Back to article page
\